- Home
- MGTX
as 01-17-2025 4:00pm EST
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 479.9M | IPO Year: | N/A |
| Target Price: | $23.50 | AVG Volume (30 days): | 337.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.85 - $7.37 | Next Earning Date: | 03-13-2025 |
| Revenue: | $13,929,000 | Revenue Growth: | 108.24% |
| Revenue Growth (this year): | -2.53% | Revenue Growth (next year): | 1391.84% |
Latest MeiraGTx Holdings plc News
MGTX Breaking Stock News: Dive into MGTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
17 days ago
High Growth Tech Stocks in the United States
Insider Monkey
21 days ago
MeiraGTx Holdings plc (MGTX): Is This Gene Therapy Stock a Good Buy Right Now?
Simply Wall St.
a month ago
Investors in MeiraGTx Holdings (NASDAQ:MGTX) have unfortunately lost 71% over the last five years
TipRanks
a month ago
MeiraGTx granted RMAT designation by U.S. FDA to AAV2-hAQP1
MT Newswires
a month ago
MeiraGTx's Xerostomia Drug Gets FDA Regenerative Medicine Advanced Therapy Designation
GlobeNewswire
a month ago
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV2-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia
PR Newswire
2 months ago
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
Simply Wall St.
2 months ago
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Compare MGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGTX MeiraGTx Holdings plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.